Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biocartis hires Hilde Windels as CFO

This article was originally published in Clinica

Executive Summary

Biocartis, a developer of molecular diagnostic solutions, has appointed Hilde Windels chief financial officer, as well as managing director of Biocartis NV (a wholly owned subsidiary of Biocartis SA) and director of Biocartis BV (the Dutch subsidiary). Ms Windels is currently on the board of MDX Health and Flanders Bio, and was previously CFO of Devgen. Biocartis was founded in 2007, and acquired its molecular diagnostics platform from Philips in February 2010 (www.clinica.co.uk, 10 February 2010). Earlier this year, Biocartis struck a deal with Johnson & Johnson to develop and commercialise assays based on its molecular diagnostics platform (www.clinica.co.uk, 10 January 2011).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT097584

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel